Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Experimental Hematology|March 24, 2007
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoirAlberto Rocci, Irene Ricca, Chiara Dellacasa, et al.
Oncotarget|August 19, 2015
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cellsMicol Rigoni, Chiara Riganti, Candida Vitale, et al.
Leukemia|July 26, 2023
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)Gabriel Scheubeck, Linmiao Jiang, Olivier Hermine, et al.
Experimental Hematology|June 14, 2002
Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvestsMarco Ladetto, Paola Omedè, Selina Sametti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphomaMarco Ladetto, Michele Magni, Gloria Pagliano, et al.
Haematologica|July 22, 2008
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemiaDavide Rossi, Antonella Zucchetto, Francesca Maria Rossi, et al.
American Journal of Hematology|August 14, 2013
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapyAlessandro Rambaldi, Cristina Boschini, Giuseppe Gritti, et al.
Hemasphere|October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphomaMats Jerkeman, Igor Aurer, Elias Campo, et al.
Hematological Oncology|November 21, 2013
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performanceIrene Della Starza, Marzia Cavalli, Ilaria Del Giudice, et al.
Blood Cancer Journal|January 19, 2022
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patientsCinzia Borgogna, Riccardo Bruna, Gloria Griffante, et al.
Pageof 14